Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Data-informed optimization of CAR T-cell therapy long-term follow-up.
Journal: Journal for immunotherapy of cancer
Published: March 11, 2026
Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+ lymphomas.
Journal: Journal for immunotherapy of cancer
Published: July 12, 2023
Immune correlates with response in patients with metastatic solid tumors treated with a tumor targeting immunocytokine NHS-IL12.
Journal: International immunopharmacology
Published: May 26, 2023
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.
Journal: The oncologist
Published: October 07, 2022
CAR T cells reach clinical milestone in prostate cancer.
Journal: Nature medicine
Published: March 22, 2022
Tumor in the Crossfire: Inhibiting TGF-β to Enhance Cancer Immunotherapy.
Journal: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
Published: February 21, 2022
Safety and Efficacy of Pembrolizumab Prior to Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia.
Journal: Transplantation and cellular therapy
Published: June 09, 2021
Extending the Promise of Chimeric Antigen Receptor T-Cell Therapy Beyond Targeting CD19+ Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 12, 2021
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume II-practical challenges.
Journal: Journal for immunotherapy of cancer
Published: October 06, 2020
Society for Immunotherapy of Cancer clinical and biomarkers data sharing resource document: Volume I-conceptual challenges.
Journal: Journal for immunotherapy of cancer
Published: August 31, 2020
A Head Start: CAR-T Cell Therapy for Primary Malignant Brain Tumors.
Journal: Current treatment options in oncology
Published: July 30, 2020
Last Updated: 09/26/2026